Sarepta Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $83.4M | $273.8M | $80.3M |
| FY2016 | $87.4M | $424.1M | $122.4M |
| FY2017 | $518.7M | $1.31B | $599.7M |
| FY2018 | $609.8M | $1.64B | $370.8M |
| FY2019 | $1.00B | $1.82B | $835.1M |
| FY2020 | $2.22B | $2.98B | $1.50B |
| FY2021 | $2.22B | $3.15B | $2.12B |
| FY2022 | $2.74B | $3.13B | $966.8M |
| FY2023 | $2.41B | $3.26B | $428.4M |
| FY2024 | $2.44B | $3.96B | $1.10B |